LABORATORY NEWS
-
Devyser Announced The Launch Of Next Generation Chimerism Analysis Solution, Strengthening Its Offering In Post-Transplant Monitoring
One Lambda Devyser Chimerism Plus is a next generation solution for chimerism analysis following allogeneic hematopoietic stem cell transplantation (HSCT). Building on the proven performance of the existing assay for chimerism monitoring, this assay features an innovative assay design that reduces the risk of errors associated with complex testing workflows while improving laboratory efficiency and ease of use.
- LigoLab Partners With MarginLogic Health AI To Deliver AI-Powered OCR For Laboratories
- Ghana's First Precision Medicine Company Completes German Development Grant Programme, Delivering Measurable Impact Across Patient Access, Diagnostic Innovation, And Clean Energy
- Zoetis Announces Agreement To Acquire VitalRADS, Accelerating Diagnostic Capabilities
- Roche Introduces Cobas Hepatitis D Virus (HDV) Test, The First Fully Automated Diagnostic Solution To Identify The Most Severe Form Of Viral Hepatitis
ARCHIVED NEWSLETTER
- 07.07.26 -- A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis
- 05.26.26 -- Engineering Repeat-Dose RNA: Engineering Around Immune Recognition In Repeat-Dose RNA Therapeutics
- 04.21.26 -- Proteomics Tools: A Resurrection
- 04.07.26 -- Navigating GMP Biosafety Challenges In ATMP Manufacturing
- 02.24.26 -- Rethinking Disease Modification Through Targeted Immunotherapy